New OB/GYN Study in Ukraine

GCT has been awarded a new randomized, double-blind, three-arm, parallel-group, multicenter superiority study in Ukraine. The goal of the trial is to assess the efficacy and safety of the drug in women suffering from endometriosis. This is a global study currently run in more than 5 countries. In Ukraine alone GCT will enroll 150 patients at 11 investigational sites.

For this project, GCT is responsible for the wide range of services including the regulatory support, site management, remote and on-site monitoring and the full cycle logistics management of the IMP, lab kits and biosamples. The project lead in Ukraine is Dmytro Mnozhynskyy, MD; he has more than 15 years of experience in clinical trials. Having successfully managed numerous women’s health clinical trials, GCT will transfer the accumulated expertise for the smooth and timely study completion.